Skip to Content
Merck
  • Glucose treatment of human pancreatic β-cells enhances translation of mRNAs involved in energetics and insulin secretion.

Glucose treatment of human pancreatic β-cells enhances translation of mRNAs involved in energetics and insulin secretion.

The Journal of biological chemistry (2021-05-30)
Albatoul Zakaria, Claire Berthault, Bertrand Cosson, Vincent Jung, Ida Chiara Guerrera, Latif Rachdi, Raphael Scharfmann
ABSTRACT

Glucose-mediated signaling regulates the expression of a limited number of genes in human pancreatic β-cells at the transcriptional level. However, it is unclear whether glucose plays a role in posttranscriptional RNA processing or translational control of gene expression. Here, we asked whether glucose affects posttranscriptional steps and regulates protein synthesis in human β-cell lines. We first showed the involvement of the mTOR pathway in glucose-related signaling. We also used the surface sensing of translation technique, based on puromycin incorporation into newly translated proteins, to demonstrate that glucose treatment increased protein translation. Among the list of glucose-induced proteins, we identified the proconvertase PCSK1, an enzyme involved in the proteolytic conversion of proinsulin to insulin, whose translation was induced within minutes following glucose treatment. We finally performed global proteomic analysis by mass spectrometry to characterize newly translated proteins upon glucose treatment. We found enrichment in proteins involved in translation, glycolysis, TCA metabolism, and insulin secretion. Taken together, our study demonstrates that, although glucose minorly affects gene transcription in human β-cells, it plays a major role at the translational level.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-α-Tubulin antibody produced in mouse, clone DM1A, ascites fluid
Sigma-Aldrich
Monoclonal Anti-β-Actin antibody produced in mouse, clone AC-15, ascites fluid
Sigma-Aldrich
Anti-Puromycin, clone 12D10, Alexa Fluor 488 Conjugate Antibody, clone 12D10, 0.5 mg/mL, from mouse